AUCTORES
Globalize your Research
Case Report
*Corresponding Author: John Davis Cantwell, Piedmont Heart Institute, 275 Collier Road, NW, Suite 500, Atlanta, Georgia 30309.
Citation: Thomas H. Murray, John D. Cantwell, (2023), Carpal Tunnel Syndrome, Ruptured Biceps Tendon, History of Spinal Stenosis, and Shoulder Arthroplasty Surgery: Risk Factors for Cardiac Amyloidosis Especially in Older Patients, Cardiology Research and Reports. 5(1); DOI:10.31579/2692-9759/093
Copyright: Thomas H. Murray, John D. Cantwell, (2023), Carpal Tunnel Syndrome, Ruptured Biceps Tendon, History of Spinal Stenosis, and Shoulder Arthroplasty Surgery: Risk Factors for Cardiac Amyloidosis Especially in Older Patients, Cardiology Research and Reports. 5(1); DOI:10.31579/2692-9759/093
Received: 31 March 2023 | Accepted: 10 April 2023 | Published: 18 April 2023
Keywords: diagnostic test; cardiac amyloidosis; carpal tunnel surgery; heart muscle; blood test
Cardiac amyloidosis, especially the wild type, is not uncommon if one looks for it in patients with certain prior orthopedic issues, as evidenced by this report of six recent cases.
With a new diagnostic test to detect cardiac amyloidosis (CA), [1,2] namely the technetium pyrophosphate (PYP) nuclear scan (Tech pyp) and also a new drug to treat the condition, tafamidis (Vyndamax), it behooves us to do a better job identifying the disorder.
A recent study showed that a man over 70 who has had bilateral carpal tunnel surgery in the past 5-15 years has a 20% chance of having CA. [3]
Other risk factors for the disease include prior rupture of a bicep’s tendon, spinal stenosis, and shoulder arthroplasty. [4]
Cardiac amyloidosis results from changes in the normal ATTR protein, originally shaped like a 4-leaf clover, produced in the liver, and transports thyroid hormone and vitamin A throughout the body. For various reasons, including heredity and aging, the 4-leaf clover can break down into the individual 4 leaves, becoming amyloid, and invading especially heart muscle and peripheral nerves.
The following six cases illustrate how the disorder can present.
Case #1
A 79 y/o former college football player had a history of a prior carpal tunnel problem. A Tech pyp scan identified cardiac amyloidosis, considered "wild type" in the absence of a positive genetic screening test and blood and urine test to exclude light chain amyloid AL (which can be found in multiple myeloma.)
Case #2
An 80 y/o former professional athlete had a history of a right carpal tunnel syndrome and several prior shoulder replacement surgeries. A Tech pyp scan was ordered and positive again for wild type cardiac amyloidosis.
The patient is on tafamidis and doing well, combining strength and endurance training.
Case #3
An 84 y/o man had a combined history of several back surgeries for spinal stenosis and the presence of peripheral neuropathy.
His evaluation determined wild type cardiac amyloidosis. A recent echocardiogram indicated an ejection fraction of 55-60% and moderate concentric left ventricular hypertrophy, along with evidence of his prior aortic valve TAVR procedure.
Despite successful cardioversion for atrial fibrillation, he remains moderately dyspneic with exercise activity.
Case #4
A 72 y/o former college athlete had a prior history of a ruptured biceps tendon.
A Tech pyp scan was positive for cardiac amyloidosis shown to be the wild type, and he has been clinically stable on tafamidis.
Case #5
A 75 y/o male college professor had a history of a right biceps’ tendon rupture and the carpal tunnel syndrome.
A Tech pyp scan was positive for cardiac amyloidosis. He is currently being worked up for likely wild type and awaiting tafamidis therapy.
He continues a distance cycling program without symptoms.
Case #6
An 82-year-old male physician had a history of prior bilateral carpal tunnel surgery. A recent article indicating a 20% chance of having cardiac amyloidosis led to a Tech pyp scan which was positive for what was eventually shown to be wild type.
Transient atrial flutter resulted in some dyspnea on his daily hour walk. When corrected he remains asymptomatic on tafamidis.
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a disease, previously considered to be rare, which is often missed as the cause of heart failure. Wild-type ATTR-CM (ATTRwt-CM) was formerly referred to as ‘senile’ ATTR-CM, as it normally occurs in later stages of life. Amyloid cardiomyopathy is caused by the deposition of amyloid fibrils in the heart. In the case of ATTR-CM, these fibrils come from the dissociation of the transthyretin (TTR) protein. TTR is mainly produced in the liver and is a transporter of retinol binding protein and Vitamin A, as well as thyroxine. TTR is a tetramer (made up of four subunits), and fibrils result from the dissociation of these subunits. The deposition of these fibrils in cardiac tissue causes thickening of the ventricular wall, ventricular stiffening, and left ventricular diastolic dysfunction.
While ATTRwt-CM makes up the majority of ATTR-CM cases, variant ATTR-CM (ATTRv-CM) is another form. ATTRv-CM is an inheritable version of ATTR-CM that is caused by a mutation in the genome, most often of Valine to Isoleucine at position 122 (V122I) of the TTR gene. This genetic mutation is most common in Black populations, with the prevalence being about 3-4% in this population.
ATTRwt-CM has been previously underdiagnosed because biopsy, often performed post-mortem, was the standard for diagnosis. However, more noninvasive screening methods have helped bring awareness and increase diagnosis of the disease. Furthermore, there is now an approved therapy specifically for cardiac amyloidosis, and other therapies are showing promising preliminary results.
When it is suspected that cardiac amyloidosis may be present in a patient, blood tests and scanning are the recommended methods of screening. First, it is important to have a serum free light chain assay, serum protein electrophoresis with immunofixation (SPIE), and preferably urine protein electrophoresis with immunofixation. These tests are important for ruling out amyloid light (AL) chain amyloidosis. AL amyloidosis is a disease caused by the deposition of immunoglobin light chain in tissues. AL cardiomyopathy (AL-CM) progresses rapidly, so it is important to ensure that this can be ruled out prior to proceeding with further ATTR-CM testing.
With AL-CM ruled out, the next step is pyrophosphate (PYP) bone scintigraphy with technetium (Tc) labeled bisphosphonates. These Tc labeled PYPs localize to amyloid and can show if there is amyloid deposition in the heart. Furthermore, a single photon emission computerized tomography (SPECT) scan is also needed to confirm that the amyloid deposition is in the myocardium and not one of the ventricles. With these labs and scans, the specificity of ATTR-CM diagnosis approaches 98%.
Along with increased ease in diagnosing ATTR-CM, newly available treatments have improved care options for patients. Currently, tafamidis is the only US-FDA approved medication for ATTR-CM. Tafamidis is a TTR stabilizer, meaning that it prevents further progression of ATTR-CM by not allowing TTR to dissociate into fibrils. In clinical trials, the patient group receiving tafamidis had a 30% reduction in all cause mortality after 30 months. Cardiovascular hospitalization was also reduced at a similar level (32%) in patients receiving tafamidis treatment. These trials also suggested that tafamidis is more effective the earlier treatment is started in regards to the disease.
While tafamidis is an exciting new therapy for ATTR-CM, its price is a significant barrier to widespread use. Currently, the price of tafamidis annually is $225,000. This high price makes it increasingly important to determine what patients will respond positively and gain the most benefit from this medication.
Other ATTR-CM therapies are currently in clinical trials. One type of therapy that is not yet approved is TTR silencing agents, such as patisiran and vutrisiran. Patisiran and vutrisiran work via small interfering RNA (siRNA) mechanisms. Inotersen is another TTR silencing agent that is effective as an antisense oligonucleotide for TTR. Excitingly, as TTR stabilizers and TTR silencers work via different mechanisms and at different points in the etiology of ATTR-CM, they potentially could be used together for treatment. Therapies that work to reverse amyloid disposition in the heart, rather than prevent further progression, are a goal. This type of therapy is approved of amyloid neuropathy, but thus far trials with cardiac amyloidosis have not been successful.
With these noninvasive screening methods and available treatments for ATTR-CM, it is increasingly important to know who and when to screen patients for the disease. The American College of Cardiology defined the population to screen for ATTR as men over 65 and women over 70 years old who have heart failure and a thickened ventricle, defined as anything 14mm or thicker. Furthermore, they have determined certain ‘red flags’ that point to a higher possibility of ATTR-CM. These red flags include reductions in global longitudinal strain, diastolic dysfunction on echocardiogram, increased left ventricular thickness, symptoms of polyneuropathy, history of bilateral carpal tunnel syndrome, and mild increases in troponin levels on multiple occasions. As bilateral carpal tunnel and polyneuropathy, along with biceps tendon rupture, shoulder replacement surgery, and spinal stenosis are red flags for ATTR-CM, it is important to spread awareness to other medical specialties so that they can look out for these and refer the patient to a cardiologist.
Tafamidis is an effective drug to treat the condition as it helps to reduce the breakdown of the ATTR protein. So-called silencing drugs are coming soon and will help subsequently reduce hepatic production of ATTR. Immunotherapy and genetic editing via CRISPR are on the horizon.
A support group (amyloidosissupport.com) helps both patients and physicians to keep up with rapid advances in the therapy of this disease.
The authors have no conflicts of interest to disclose.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
